5-Methyltetrahydrohomofolate. 1987

P J O'Dwyer, and B H Wagner, and D F Hoth, and B Leyland-Jones
Investigational Drug Branch, National Cancer Institute, Philadelphia.

5-methyltetrahydrohomofolate was developed in the 1970's as an antifolate with the potential to overcome methotrexate resistance. This review summarizes the preclinical and clinical data which have accumulated to date. It is concluded that more recent, better characterized antifolates offer greater potential in achieving the goals for which this drug was introduced.

UI MeSH Term Description Entries
D004341 Drug Evaluation Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation
D005492 Folic Acid A member of the vitamin B family that stimulates the hematopoietic system. It is present in the liver and kidney and is found in mushrooms, spinach, yeast, green leaves, and grasses (POACEAE). Folic acid is used in the treatment and prevention of folate deficiencies and megaloblastic anemia. Pteroylglutamic Acid,Vitamin M,Folacin,Folate,Folic Acid, (D)-Isomer,Folic Acid, (DL)-Isomer,Folic Acid, Calcium Salt (1:1),Folic Acid, Monopotassium Salt,Folic Acid, Monosodium Salt,Folic Acid, Potassium Salt,Folic Acid, Sodium Salt,Folvite,Vitamin B9,B9, Vitamin
D005493 Folic Acid Antagonists Inhibitors of the enzyme, dihydrofolate reductase (TETRAHYDROFOLATE DEHYDROGENASE), which converts dihydrofolate (FH2) to tetrahydrofolate (FH4). They are frequently used in cancer chemotherapy. (From AMA, Drug Evaluations Annual, 1994, p2033) Antifolate,Antifolates,Dihydrofolate Reductase Inhibitor,Folic Acid Antagonist,Dihydrofolate Reductase Inhibitors,Folic Acid Metabolism Inhibitors,Acid Antagonist, Folic,Acid Antagonists, Folic,Antagonist, Folic Acid,Antagonists, Folic Acid,Inhibitor, Dihydrofolate Reductase,Inhibitors, Dihydrofolate Reductase,Reductase Inhibitor, Dihydrofolate,Reductase Inhibitors, Dihydrofolate
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000964 Antimetabolites, Antineoplastic Antimetabolites that are useful in cancer chemotherapy. Antineoplastic Antimetabolites

Related Publications

P J O'Dwyer, and B H Wagner, and D F Hoth, and B Leyland-Jones
August 1981, The Journal of pharmacology and experimental therapeutics,
P J O'Dwyer, and B H Wagner, and D F Hoth, and B Leyland-Jones
February 1983, Cancer research,
P J O'Dwyer, and B H Wagner, and D F Hoth, and B Leyland-Jones
January 1981, Cancer treatment reports,
P J O'Dwyer, and B H Wagner, and D F Hoth, and B Leyland-Jones
February 1979, Cancer treatment reports,
P J O'Dwyer, and B H Wagner, and D F Hoth, and B Leyland-Jones
October 1998, The Journal of organic chemistry,
P J O'Dwyer, and B H Wagner, and D F Hoth, and B Leyland-Jones
January 2009, Soins; la revue de reference infirmiere,
P J O'Dwyer, and B H Wagner, and D F Hoth, and B Leyland-Jones
May 1962, Archiv der Pharmazie und Berichte der Deutschen Pharmazeutischen Gesellschaft,
P J O'Dwyer, and B H Wagner, and D F Hoth, and B Leyland-Jones
July 1948, Journal of the American Chemical Society,
P J O'Dwyer, and B H Wagner, and D F Hoth, and B Leyland-Jones
April 1972, Doklady Akademii nauk SSSR,
Copied contents to your clipboard!